CohBar, Inc. to Hold 2016 Annual Shareholder Meeting and Investor Update June 14, 2016

Spotlight Companies  |

MENLO PARK, Calif.--()--CohBar, Inc. (OTCQX: CWBR and TSXV: COB.U), an innovative biotechnology company focused on developing mitochondria-based therapeutics (MBTs) to treat diseases associated with aging, is hosting its Annual Shareholder Meeting on June 14, 2016.

Details for the Annual Shareholder Meeting:

Date: June 14, 2016
Time: 12:30 p.m. (Pacific Time)
Live Webcast: http://www.virtualshareholdermeeting.com/COB16.

Following the Annual Shareholder Meeting, CohBar will host a conference call and WebEx slide presentation to provide a corporate update for investors.

Details for the Investor Call and WebEx:

Date: June 14, 2016
Time: 1:00 p.m. (Pacific Time)
Audio, Dial-in U.S. and Canada: (888) 438-5525
Audio, Dial-in International: (719) 325-2244
Conference ID# 6467126
Slide Presentation, WebEx: https://meetings.webex.com/collabs/#/meetings/deta...

For individuals participating in the Investor Call and WebEx, we request you please call into the audio and log into WebEx approximately 5-10 minutes before the 1 p.m. PT start of the presentation so that we can begin promptly.

About CohBar

CohBar (OTCQX: CWBR and TSXV: COB.U) is a leader in the research and development of mitochondria-based therapeutics, an emerging class of drugs for the treatment of diseases associated with aging. MBTs originate from the discovery of a novel group of peptides within the genome of mitochondria, the powerhouses of the cell. This groundbreaking discovery was made by our founders, world leaders in the biology of aging, metabolism and mitochondrial genomics. MBTs offer the potential to address a broad range of diseases such as type 2 diabetes, cancer, atherosclerosis and neurodegenerative disorders.

For additional company information, please visit www.cohbar.com.

Contacts

CohBar, Inc.
Jeff Biunno, 650-446-7888 ext. 109
CFO
jeff.biunno@cohbar.com
or
MacDougall Biomedical Communications
Heather Savelle, 781-235-3060
hsavelle@macbiocom.com

In the interest of full disclosure, we call the reader's attention to the fact that Equities.com, Inc. is compensated by the companies profiled in the Spotlight Companies section. The purpose of these profiles is to provide awareness of these companies to investors in the micro, small-cap and growth equity community and should not in any way be considered as a recommendation to buy, sell or hold these securities. Equities.com is not a registered broker dealer, investment advisor, financial analyst, investment banker or other investment professional. We are a publisher of original and third party news and information. All profiles are based on information that is available to the public. The information contained herein should not be considered to be complete and is not guaranteed by Equities.com to be free from misstatement or errors. The views expressed are our own and not intended to be the basis for any investment decision. Readers are reminded to do their own due diligence when researching any companies mentioned on this website. Always bear in mind that investing in early-stage companies is risky and you are encouraged to only invest an amount that you can afford to lose completely without any change in your lifestyle.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not necessarily represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer.

Watchlist

Symbol Last Price Change % Change
AAPL

     
AMZN

     
HD

     
JPM

     
IBM

     
BA

     
WMT

     
DIS

     
GOOG

     
XOM

     
BRK.A

     
FB

     
JNJ

     
WFC

     
T

     
NFLX

     
TSLA

     
V

     
UNH

     
PG